---
schema_version: "secwatch.filing_event.v1"
accession: "0001827090-25-000034"
form_type: "8-K"
ticker: "CERT"
cik: "0001827090"
company_name: "Certara, Inc."
filed_at: "2025-08-06T23:59:59+00:00"
generated_at: "2026-05-17T19:52:45.909034+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Certara Q2 2025 revenue $104.6M (+12% YoY); net loss narrows to $2.0M; reiterates FY guidance

## Summary
- Revenue $104.6M (+12% YoY); software revenue $46.7M (+22%), services $57.9M (+5%).
- Net loss improved 84% to $2.0M from $12.6M in Q2 2024.
- Adjusted EBITDA $31.9M (+21% YoY); Chemaxon contributed $5.3M to revenue.
- Full-year 2025 financial guidance reaffirmed, citing sustained demand for model-informed drug development.
- CEO highlighted software product enhancements and new product introductions driving long-term growth.

## SEC filing metadata
- accession: 0001827090-25-000034
- form_type: 8-K
- ticker: CERT
- cik: 0001827090
- company_name: Certara, Inc.
- filed_at: 2025-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1827090/000182709025000034/0001827090-25-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1827090/000182709025000034/certara-20250806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001827090-25-000034
- JSON: https://secwatch.observer/filing/0001827090-25-000034.json
- Plain text: https://secwatch.observer/filing/0001827090-25-000034.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.